JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 May 2008

J Neurol Neurosurg Psychiatry. Published Online First: 31 August 2007. doi:10.1136/jnnp.2007.123323
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jnnp.2007.123323v1
79/5/522    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klostermann, F.
Right arrow Articles by Sappok, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klostermann, F.
Right arrow Articles by Sappok, T.

Original articles

Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease

Fabian Klostermann 1*, Felicitas Ehlen 1, Jan Vesper 2, Karsten Nubel 3, Manfred Gross 3, Frank Marzinzik 1, Gabriel Curio 1 and Tanja Sappok 1

1 Charité - University Medicine Berlin, Department of Neurology, Germany
2 University Clinic of Freiburg, Department of Stereotactic Neurosurgery, Germany
3 Charité - University Medicine Berlin, Deparment of Audiology and Phoniatrics, Germany

* To whom correspondence should be addressed. E-mail: fabian.klostermann{at}charite.de.

Accepted 13 August 2007


*  Abstract

Background: Motor deficits in Parkinson’s disease (PD) are reduced by Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN), but the impact of this therapy on dysarthrophonic problems in PD remains controversial. We, therefore, aimed at disentangling the effects of STN DBS on the speech skills of long-term treated patients.

Methods: Under continued medication, speech and motor functions of 19 PD patients with bilateral STN DBS were studied when their therapeutic stimulation was active (STIM-ON) versus switched off (STIM-OFF). Per condition, perceptual speech ratings were given by (i) the patients themselves, (ii) the treating physician and (iii) professional speech therapists. Further, single speech parameters were measured with a battery of technical exams in both STIM-ON and STIM-OFF.

Results: STN DBS significantly worsened speech performance according to all perceptual rating methods applied. Contrarily, technical measures showed DBS-induced improvements of single speech dimensions affected by the PD-specific motor disorder. These changes occurred independently of the reduction of motor impairment, consistently effectuated by STN DBS.

Conclusion: In parallel to the beneficial effects of STN DBS on the motor symptoms of PD, it reduces designated disease-inherent dysarthrophonic symptoms, such as glottic tremor. However, these actions on speech are predominantly outweighed by general dysarthrogenic effects of STN DBS, probably based on a decline of complex, e.g., prosodic functions. Thus, on condition of the reduced antiparkinsonian medication under DBS STN, stimulation-induced speech impairment should be considered a likely problem in the course of the treatment.


Keywords: Deep Brain Stimulation, Dysarthrophonia, Parkinson's disease, STN







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.